Literature DB >> 7064208

Changes in coagulation factors, complement, immunoglobulins, and immune complex concentrations with plasma exchange.

R L Volkin, T W Starz, A Winkelstein, R K Shadduck, J H Lewis, U Hasiba, J A Spero.   

Abstract

Seventeen patients with a spectrum of immunologically-related disorders were studied before and immediately after plasma exchange (PE) for changes in coagulation factors, complement, immunoglobulins, and immune complex levels. Each PE replaced 50 per cent of the plasma volume with 5% albumin and saline. With PE, coagulation profiles indicated a decrease of 23 to 55 per cent in the levels of fibrinogen, Factors II, V, VII, VIII, IX, X, XI, XII, and Fletcher factor. Only minimal changes were noted in the prothrombin time and activated partial thromboplastin time. Most coagulation factors, except fibrinogen, returned to baseline by 48 hours. Following three PE/week, fibrinogen was reduced by 51 per cent; other factors were not significantly altered. C3 and C4 fell by 35 to 40 per cent with each PE; these approached baseline by 24 hours. Immunoglobulins (G,A,M) were reduced by 34 +/- 3,37 +/- 3 and 34 +/- 3 per cent, respectively. After three PE, the total immunoglobulins were decreased by 50 to 55 per cent. Five of eight patients who had three or more PE developed hypogammaglobulinemia (IgG less than 450 mg/dl). Immune complexes were reduced by 50 +/- 4 per cent with each PE. Multiple exchanges in five patients led to a greater reduction (80 +/- 6%). Thus PE was an effective means of reducing immune complexes but led to hypogammaglobulinemia and hypofibrinogenemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7064208     DOI: 10.1046/j.1537-2995.1982.22182154218.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Removal kinetics of therapeutic apheresis.

Authors:  Roberto Reverberi; Lorenzo Reverberi
Journal:  Blood Transfus       Date:  2007-07       Impact factor: 3.443

2.  Selective plasma exchange for multiple sclerosis with optic neuritis.

Authors:  Masahiro Mimori; Takeo Sato; Shusaku Omoto; Kenichiro Sakai; Hidetaka Mitsumura; Yasuyuki Iguchi
Journal:  Neurol Clin Pract       Date:  2020-08

3.  Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.

Authors:  Jeffrey T Guptill; Vern C Juel; Janice M Massey; Amanda C Anderson; Manisha Chopra; John S Yi; Ehsanollah Esfandiari; Tim Buchanan; Bryan Smith; Paul Atherfold; Emma Jones; James F Howard
Journal:  Autoimmunity       Date:  2016-08-11       Impact factor: 2.815

4.  Clinical outcome measures following plasma exchange for MG exacerbation.

Authors:  Shruti M Raja; James F Howard; Vern C Juel; Janice M Massey; Manisha Chopra; Jeffrey T Guptill
Journal:  Ann Clin Transl Neurol       Date:  2019-09-27       Impact factor: 4.511

5.  IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes.

Authors:  Massimiliano Montagna; Rizvana Amir; Ilse De Volder; Martin Lammens; Jef Huyskens; Barbara Willekens
Journal:  Front Neurol       Date:  2018-05-17       Impact factor: 4.003

6.  The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins.

Authors:  Willie D Taylor; Gregory L Langham; James L Weed; Thomas Rowe; Wei Song; Kristin A Isenberg; Xiyan Xu; David E Wentworth; George Lathrop; Nathaniel Powell
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.